Agiliti(US:AGTI) Zacks Investment Research·2024-03-05 23:36Core Insights - Agiliti (AGTI) reported quarterly earnings of $0.13 per share, exceeding the Zacks Consensus Estimate of $0.12 per share, but down from $0.18 per share a year ago, indicating an earnings surprise of 8.33% [1] - The company generated revenues of $291.99 million for the quarter, matching the Zacks Consensus Estimate and reflecting a year-over-year increase from $281.68 million [1] - Agiliti's stock has increased by approximately 24.9% since the beginning of the year, outperforming the S&P 500's gain of 7.6% [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.15, with expected revenues of $315.01 million, while the estimate for the current fiscal year is $0.58 on $1.22 billion in revenues [4] - The trend for earnings estimate revisions for Agiliti has been unfavorable, resulting in a Zacks Rank 4 (Sell), suggesting expected underperformance in the near future [3] Industry Context - The Medical Services industry, to which Agiliti belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [4] - Another company in the same industry, MDxHealth SA Sponsored ADR, is expected to report results for the quarter ended December 2023 on March 6, with a projected quarterly loss of $0.28 per share, representing a year-over-year change of +74.6% [5]